Drug
Perseris
Perseris: highest development phase Post-Market, developed by Indivior. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| PERSERIS NCT03978832 | Post-Market | Schizophrenia |
Latest
No recent events.
Follow Perseris on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.